Pfizer (PFE) implied volatility at low end of range into Halted development of Heart-disease Treatment
Tweet Send to a Friend
Pfizer (NYSE: PFE) : PFE ended development of new cholesterol medicine designed to replace Lipitor ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
